Simile Raises $200M at $2B Valuation in Series B Funding Round
Synthetic-user startup Simile has raised a $200 million Series B round, valuing the company at $2 billion just five months after securing a $100 million Series A led by Index Ventures. The latest funding was spearheaded by Greenoaks and included participation from several other venture capital firms as well as CVS Health Ventures, which is also one of Simile’s major clients. Founded by Stanford PhD graduate Joon Sung Park, the company provides simulated users for marketing and product research applications. While its mission to simulate all eight billion people on earth has been described as ambitious or unrealistic due to human unpredictability, synthetic user testing remains a promising area in AI-driven market research. Other startups like Aaru have also attracted significant venture capital interest recently. The rapid growth of Simile highlights the increasing investor confidence in AI and synthetic data technologies for business applications.
Topics: AI startup Fundraising Startups synthetic data